| P2093 | author name string | Yang Yang | |
| | Ping Li | |
| | Kuo Yang | |
| | Guodong Zhu | |
| | Xuezhong Zhou | |
| | Teng Hao | |
| | Ruby Ling | |
| P2860 | cites work | The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored | Q24607390 |
| | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 |
| | Atrial natriuretic peptide in cardiovascular biology and disease (NPPA) | Q28082833 |
| | A Systems Approach to Refine Disease Taxonomy by Integrating Phenotypic and Molecular Networks. | Q52579854 |
| | Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. | Q53359008 |
| | Molecular assembly of endogenous and synthetic big atrial natriuretic peptide (ANP) and its amyloidogenic implications | Q60631814 |
| | Quinapril prevents hypertension and enhanced vascular reactivity in nitroarginine-treated rats | Q73229623 |
| | [Network pharmacology: new opportunity for the modernization of traditional Chinese medicine] | Q84864419 |
| | The Therapeutical Effect of Chinese Medicine for the Treatment of Atherosclerotic Coronary Heart Disease | Q88697455 |
| | Network pharmacology: the next paradigm in drug discovery | Q28297997 |
| | Network-Based Approach to Identify Potential Targets and Drugs that Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke | Q28584257 |
| | Network medicine: a network-based approach to human disease | Q29547462 |
| | cAMP-dependent cell differentiation triggered by activated CRHR1 in hippocampal neuronal cells. | Q29994681 |
| | Multiple plasma proteins control atrial natriuretic peptide (ANP) aggregation. | Q31125491 |
| | Cardiovascular endocrinology: introduction | Q35146306 |
| | Corticotropin releasing hormone and imaging, rethinking the stress axis | Q35181618 |
| | Disease networks. Uncovering disease-disease relationships through the incomplete interactome | Q35619320 |
| | Corticotropin-Releasing Hormone (CRH) Promotes Macrophage Foam Cell Formation via Reduced Expression of ATP Binding Cassette Transporter-1 (ABCA1). | Q35674458 |
| | Vasoprotective actions of the atrial natriuretic peptide. | Q36002795 |
| | Role of NeuroD1 on the negative regulation of Pomc expression by glucocorticoid | Q36345916 |
| | Untangling the role of amyloid in atherosclerosis. | Q36589022 |
| | Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets | Q37173042 |
| | A novel GABA-mediated corticotropin-releasing hormone secretory mechanism in the median eminence | Q37183981 |
| | Atrial natriuretic Peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation | Q37195866 |
| | A review of the role of atrial natriuretic peptide gene polymorphisms in hypertension and its sequelae. | Q37369247 |
| | 11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice | Q37687153 |
| | TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure | Q37771751 |
| | Network pharmacology in traditional chinese medicine. | Q38269825 |
| | Cytokine signature associated with disease severity in chronic fatigue syndrome patients | Q38650803 |
| | Mechanistic insights into GPCR-G protein interactions | Q39015587 |
| | Biogenesis, assembly and trafficking of acetylcholinesterase | Q39192264 |
| | Mental disorders and coronary heart disease risk: could the evidence elude us while we sleep? | Q42507805 |
| | Identifying functional modules in protein-protein interaction networks: an integrated exact approach | Q42646303 |
| | Human symptoms-disease network | Q42668669 |
| | Co-expression Network Approach Reveals Functional Similarities among Diseases Affecting Human Skeletal Muscle | Q47135441 |
| | Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis | Q47138484 |
| | The Psychoactive Agent Crocin Can Regulate Hypothalamic-Pituitary-Adrenal Axis Activity. | Q47159914 |
| | Molecular Mechanisms of GPCR Signaling: A Structural Perspective | Q47255137 |
| | Exploring traditional chinese medicine by a novel therapeutic concept of network target | Q47313274 |
| | APOA1 and APOA4 gene polymorphisms influence the effects of dietary fat on LDL particle size and oxidation in healthy young adults | Q47444768 |
| | Enhanced Hypothalamic NMDA Receptor Activity Contributes to Hyperactivity of HPA Axis in Chronic Stress in Male Rats. | Q47826161 |
| | Small HDL form via apo A-I a complex with atrial natriuretic peptide. | Q47971544 |
| | Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association | Q49546493 |
| | Integrated Modules Analysis to Explore the Molecular Mechanisms of Phlegm-Stasis Cementation Syndrome with Ischemic Heart Disease | Q49744076 |
| | Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury | Q50044861 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P304 | page(s) | 489 | |
| P577 | publication date | 2018-05-08 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Prediction of Molecular Mechanisms for LianXia NingXin Formula: A Network Pharmacology Study. | |
| P478 | volume | 9 | |